Presentation is loading. Please wait.

Presentation is loading. Please wait.

Intravenous delivery of reovirus to primary and secondary brain tumors

Published byGabriella Jennings Modified over 6 years ago

Similar presentations

Presentation on theme: "Intravenous delivery of reovirus to primary and secondary brain tumors"— Presentation transcript:

1 Fig. 1 Intravenous delivery of reovirus to primary and secondary brain tumors.
Intravenous delivery of reovirus to primary and secondary brain tumors. (A) Representative immunohistochemistry (IHC) and in situ hybridization (ISH) trial and control patient tumor sections stained for reovirus σ3 protein (brown, top) and reovirus RNA (blue, bottom). The “control breast met” is a metastasis to the brain from a breast cancer primary. Arrows point to examples of positive cells/positive areas of tissue. Scale bars, 20 μm. HGG, high-grade glioma. (B) Trial and control patient tumor immunogold-TEM images for reovirus σ3 protein (arrows). CRC, colorectal cancer. Scale bars, 200 nm. (C) Quantitative reverse transcription polymerase chain reaction for reovirus σ3 gene, using whole tumor RNA. Data indicate femtograms (fg) reovirus RNA per microgram of whole tumor RNA. Histogram shows the mean of triplicate samples, and error bars indicate SD. (D) Representative immunofluorescence (IF) of trial patient tumor sections showing staining for reovirus RNA (blue), reovirus σ3 protein (red), and their coexpression (yellow). Scale bars, 80 μm. Adel Samson et al., Sci Transl Med 2018;10:eaam7577 Published by AAAS

Download ppt "Intravenous delivery of reovirus to primary and secondary brain tumors"

Similar presentations

Fig. 1. TP is highly expressed in myeloma.

Fig. 1. TP is highly expressed in myeloma.
Examples of functional imaging biomarkers in two DCA responders

Examples of functional imaging biomarkers in two DCA responders
Fig. 4. Primary human metastatic melanomas contain CCL21-expressing LECs, and expression of VEGFC positively correlates with hallmarks of tumor inflammation.

Fig. 4. Primary human metastatic melanomas contain CCL21-expressing LECs, and expression of VEGFC positively correlates with hallmarks of tumor inflammation.
Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.

Fig. 2. LUM015 fluorescently labels tumor cells in mouse models of STS and breast cancer. LUM015 fluorescently labels tumor cells in mouse models of STS.
Nat. Rev. Clin. Oncol. doi: /nrclinonc

Nat. Rev. Clin. Oncol. doi: /nrclinonc
Fig. 3. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures.

Fig. 3. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures.
Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.

Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.
PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.

PD-1 and LAG-3 expression in MSI and MSS colorectal cancer specimens.
Fig. 3. Obese IFN-γ−/− mice develop accelerated NAFLD with fibrosis.

Fig. 3. Obese IFN-γ−/− mice develop accelerated NAFLD with fibrosis.
Geographic distribution in situ of MSI and MSS colorectal cancer–infiltrating lymphocytes. Geographic distribution in situ of MSI and MSS colorectal cancer–infiltrating.

Geographic distribution in situ of MSI and MSS colorectal cancer–infiltrating lymphocytes. Geographic distribution in situ of MSI and MSS colorectal cancer–infiltrating.
Fig. 6. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex vivo. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex.

Fig. 6. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex vivo. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex.
Analysis of brain and spinal cord of treated Gaa−/− mice and controls

Analysis of brain and spinal cord of treated Gaa−/− mice and controls
Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.

Fig. 2 TLR8 is aberrantly expressed on pDCs from SSc patients.
Fig. 4. Prion infectivity of skin samples from sCJD patients.

Fig. 4. Prion infectivity of skin samples from sCJD patients.
Fig. 4 Infection-induced CLV dysfunction is associated with decreased LMC coverage. Infection-induced CLV dysfunction is associated with decreased LMC.

Fig. 4 Infection-induced CLV dysfunction is associated with decreased LMC coverage. Infection-induced CLV dysfunction is associated with decreased LMC.
Fig. 4 Bone tissue formation within the Ti-mesh channels.

Fig. 4 Bone tissue formation within the Ti-mesh channels.
Fig. 2. GPC3 expression in normal and tumor tissues.

Fig. 2. GPC3 expression in normal and tumor tissues.
Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.

Fig. 5. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic mice. Antitumor efficacy of ERY974 in immunocompetent human CD3 transgenic.
Fig. 5. Immunohistochemistry of the tumor microenvironment in GBM specimens before and after CART-EGFRvIII infusion. Immunohistochemistry of the tumor.

Fig. 5. Immunohistochemistry of the tumor microenvironment in GBM specimens before and after CART-EGFRvIII infusion. Immunohistochemistry of the tumor.
Fig. 1. Paclitaxel delays tumor growth and promotes infiltration of TIE2hi/VEGFhi macrophages and TMEM assembly. Paclitaxel delays tumor growth and promotes.

Fig. 1. Paclitaxel delays tumor growth and promotes infiltration of TIE2hi/VEGFhi macrophages and TMEM assembly. Paclitaxel delays tumor growth and promotes.

Similar presentations

Ads by Google